Bookmark

Add to MyYahoo RSS

Novo Nordisk AS News

News on Novo Nordisk AS (Ticker: NVO) continually updated from thousands of sources around the net.

11 hrs ago | Investor's Business Daily

Top Mutual Fund Manager Seeks Mispriced Growth

He waits for them to focus on short-term factors in a good security's price in the stock market today . When they flee from the stock, driving down its price, Hamzaogullari pounces.

Comment?

Related Topix: Financial Markets, Biotech

17 hrs ago | BioSpace

Study Shows Novo Nordisk A/S's New Diabetes Drug Tresiba Effective And Safe For Children

New data show long-term efficacy and safety of Tresiba in children and adolescents with type 1 diabetes Vienna, Austria, 16 September - Today, at the 50 Annual Meeting of the European Association for the Study of Diabetes , Novo Nordisk announced new data from the BEGIN versus insulin detemir, both in combination with bolus insulin aspart in a 52-week trial in children and adolescents with type 1 diabetes. This trial is the first to look into the long-term safety of Tresiba "When treating children and adolescents with type 1 diabetes, it is critical that the right balance between glycaemic control and side effect management is maintained to ensure the best possible long-term outcomes.

Comment?

Related Topix: Diabetes, Health, Biotech, World News, Austria, Insulin (generic), Humulin, Novolin, Norfolk County, England, United Kingdom

21 hrs ago | South China Morning Post

Novo's weight-loss shot wins backing of U.S. advisers

Students wait in line to get a meal at Wellspring Academy, which is a special school that helps teens and college level students lose weight along with academic courses. Photo: AFP A weight-loss drug from Novo Nordisk helped people get thinner, U.S. regulators said, as the Danish drugmaker became the latest to push a pharmaceutical remedy for America's obesity woes.

Comment?

Related Topix: Biotech, Medicine, Diabetes

Mon Sep 15, 2014

Freshnews

Congress, MAGIC Call for Early Detection and Awareness of Children's Growth Patterns

The MAGIC Foundation , a nonprofit organization that provides support services for the families of children afflicted with a wide variety of chronic and/or critical disorders, syndromes, and diseases that affect a child's growth, is proud to support, in partnership with Novo Nordisk, the first nationally recognized Growth Awareness Week. This is a significant milestone for children everywhere because it puts a national spotlight on the need for parents to better educate themselves on proper growth patterns.

Comment?

Related Topix: Non-Profit, Biotech, US Politics, Senator Mark Kirk, US News, US Senate, Republican

Sun Sep 14, 2014

NEWS.com.au

FDA panel backs Novo Nordisk injection

FEDERAL health experts say Novo Nordisk's diabetes drug Victoza should be approved for a new use in treating obesity. THE panel of Food and Drug Administration advisers voted 14-1 that the injectable drug's benefits outweigh its risks for patients who are obese or dangerously overweight.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin

Financial Times

Novo Nordisk and the diabetes epidemic

Sep 14, 2014 : Rising insulin sales have made Novo Nordisk one of the strongest growth stories in the pharma sector.

Comment?

Related Topix: Biotech, Epidemic, Medicine, Diabetes, Natural Disasters, Health, Insulin (generic), Humulin, Novolin

Fri Sep 12, 2014

Seeking Alpha

Novo Gets Positive Vote From FDA For Anti-Obesity Treatment - Still A Long Road Ahead

Novo Nordisk received good news earlier this week in its quest to get an obesity indication for its drug Saxenda. The drug is a different dose form of liaglutide that would be injected once a day for patienmts seeking to treat obesity.

Comment?

Related Topix: Biotech, Food and Drug Administration, Medicine, Diabetes, Health, Startups, VIVUS, Healthcare Industry, Arena Pharmaceuticals

The Motley Fool

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr

A heavier population has significantly increased concerns over obesity's impact on global health, resulting in a flurry of drug development activity and FDA approval of weight loss pills. ) novel anti-obesity pills are among three drugs that the FDA has approved for use alongside diet and exercise to promote weight loss.

Comment?

Related Topix: Medicine, Health, Diabetes, Biotech

Reuters

UPDATE 3-U.S. FDA panel: Novo Nordisk's liraglutide safe, effective for obesity

Novo Nordisk's drug liraglutide is safe and effective enough to warrant approval for use in chronically obese patients with at least one weight-related health issue, an advisory panel to the U.S. Food and Drug Administration said on Thursday. The positive vote sent shares in the company, the Nordic region's most valuable by market capitalisation, to an all-time high of 275.60 Danish crowns on Friday, up more than 3 percent.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Insulin (generic), Humulin, Novolin

Thu Sep 11, 2014

Freshnews

Saxenda for the treatment of obesity receives positive 14-1 vote in...

Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration has completed its meeting regarding the New Drug Application for Saxenda , the intended brand name for liraglutide 3 mg, a once-daily human GLP-1 analogue for the treatment of obesity. Based on the data contained in the NDA for Saxenda , the FDA asked the panel members to discuss whether Novo Nordisk has provided adequate evidence to establish the efficacy and safety profile of Saxenda for chronic weight management.

Comment?

Related Topix: Food and Drug Administration, Biotech, Marketing, Diabetes, Health

KRON 4

FDA Approves New Weight Loss Injection

Federal health experts say a diabetes drug from Novo Nordisk should be approved for a new use in treating obesity. The panel of Food and Drug Administration advisers voted 14-1 that the injectable drug's benefits outweigh it risks for patients who are obese or dangerously overweight.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin

CBS Atlanta

FDA panel backs Novo Nordisk injection for obesity

Prosecutors are wrapping up their case against the owner of a Georgia peanut plant linked to a deadly salmonella outbreak, saying he knowingly approved shipments of tainted food "whatever the risk." The owner of a Georgia peanut plant where a deadly salmonella outbreak originated five years ago approved sales of tainted food "whatever the risk," including shipments known to have tested positive for the bacteria and... A 40-year-old driver has been accused of intentionally driving a pickup truck through the glass doors of the Stratosphere casino on the Las Vegas Strip.

Comment?

Related Topix: Food and Drug Administration, Biotech, Georgia, Stratosphere, Gaming, George Bush

Wed Sep 10, 2014

South China Morning Post

New obesity drug wins FDA approval, and this time it could take off

Students wait in line to get a meal at Wellspring Academy, which is a special school that helps teens and college level students lose weight along with academic courses. Photo: AFP The US Food and Drug Administration has endorsed the weight-loss capabilities of a new drug from Novo Nordisk, as the Danish drugmaker became the latest to push a pharmaceutical remedy for America's obesity woes.

Comment?

Related Topix: Food and Drug Administration, Biotech, Orexigen Therapeutics, Medicine, Diabetes, Health

Tue Sep 09, 2014

Reuters

UPDATE 1-FDA staff: Novo Nordisk drug liraglutide effective for obesity

Novo Nordisk's drug liraglutide appears effective in treating obesity, though safety questions remain, according to a preliminary assessment by reviewers at the U.S. Food and Drug Administration. The report, posted on the agency's website on Tuesday, noted an imbalance in the number of breast malignancies in women who took the drug, but said the available data neither supports nor denies the potential role of the drug in cancer promotion or progression.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Diabetes, Health

Mon Sep 08, 2014

Bloomberg

More Obesity Drugs Seek to Enter Still Struggling Market

Drugmakers aren't giving up on a pharmaceutical remedy for America's obesity woes even as sales for much-anticipated weight-loss pills have fallen short of estimates. The Food and Drug Administration is scheduled to decide by Sept.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Eisai Co, Startups, VIVUS, Medicare, Medicaid, Health

Thu Sep 04, 2014

Forbes.com

Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists

I was the president of Pfizer Global Research and Development in 2007 where I managed more than 13,000 scientists and professionals in the United States, Europe, and Asia. I've received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.

Comment?

Related Topix: Biotech, University of New Hampshire, Genetics, Medicine, Oncology, Business News

Business World

Merrion Pharma get milestone payment

Dublin's Merrion Pharmaceuticals today said that it has received a milestone payment from its partner, Novo Nordisk, after a Phase 1 clinical trial with an oral diabetes-fighting drug. This class of compound stimulates the release of insulin in appropriate diabetic subjects, and is currently administered by injection.

Comment?

Related Topix: Biotech, Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin, Pharmacology

Wed Sep 03, 2014

Seattle Times

Novo Nordisk cuts 63 jobs at Seattle research site

Danish pharmaceutical company Novo Nordisk is eliminating 63 Seattle jobs and closing its inflammation research center, dealing the second recent blow to the local biotechnology sector from a large drug developer.

Comment?

Related Topix: Biotech, Rheumatoid Arthritis, Medicine, Health

Tue Sep 02, 2014

WCAX-TV Burlington

Denmark company buys NH biotech plant

A Denmark company has purchased a biotech plant in West Lebanon that was closing down.

Comment?

Related Topix: Biotech, Lyndonville, VT, Albany, VT, St. Albans, VT, Marijuana

GuruFocus.com

Baxter Will Remain Diversified and With Competitive Advantages

In this article, let's take a look at Baxter International Inc. , a $40.61 billion market cap company, which is a global medical products and services company that provides critical therapies for people with life-threatening conditions.

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry, Biotech, Pfizer, Abbott Laboratories, Bristol Myers Squibb

•••
•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••